SERAFINI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 6.236
AS - Asia 5.478
EU - Europa 3.633
SA - Sud America 798
AF - Africa 146
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.311
Nazione #
US - Stati Uniti d'America 5.936
SG - Singapore 1.757
IT - Italia 1.347
CN - Cina 1.010
VN - Vietnam 970
HK - Hong Kong 711
BR - Brasile 618
RU - Federazione Russa 536
DE - Germania 367
IE - Irlanda 282
SE - Svezia 256
CA - Canada 224
GB - Regno Unito 171
IN - India 166
FR - Francia 157
BD - Bangladesh 156
ID - Indonesia 131
KR - Corea 115
FI - Finlandia 106
UA - Ucraina 83
TR - Turchia 76
AR - Argentina 67
ES - Italia 64
JP - Giappone 62
IQ - Iraq 61
ZA - Sudafrica 54
PK - Pakistan 53
NL - Olanda 51
PL - Polonia 42
MX - Messico 40
SA - Arabia Saudita 36
CH - Svizzera 32
CO - Colombia 30
AT - Austria 29
BE - Belgio 27
EC - Ecuador 27
IR - Iran 25
PH - Filippine 25
EG - Egitto 20
MA - Marocco 16
CL - Cile 15
AU - Australia 14
DK - Danimarca 13
RO - Romania 13
VE - Venezuela 13
ET - Etiopia 12
MY - Malesia 11
PY - Paraguay 11
TN - Tunisia 11
UZ - Uzbekistan 11
IL - Israele 10
JO - Giordania 10
LT - Lituania 10
TW - Taiwan 10
JM - Giamaica 9
NO - Norvegia 9
NP - Nepal 9
CZ - Repubblica Ceca 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
KZ - Kazakistan 7
TH - Thailandia 7
UY - Uruguay 7
LB - Libano 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
GR - Grecia 5
HN - Honduras 5
NI - Nicaragua 5
PE - Perù 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
AZ - Azerbaigian 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
KG - Kirghizistan 3
LV - Lettonia 3
SC - Seychelles 3
XK - ???statistics.table.value.countryCode.XK??? 3
AG - Antigua e Barbuda 2
AM - Armenia 2
GA - Gabon 2
GY - Guiana 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
NG - Nigeria 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
Totale 16.294
Città #
Singapore 1.060
Ann Arbor 820
Hong Kong 675
Ashburn 639
San Jose 584
Milan 435
Ho Chi Minh City 317
Dublin 277
Chandler 268
Hanoi 232
Los Angeles 209
Hefei 208
Fairfield 186
Houston 185
Frankfurt am Main 183
Wilmington 169
New York 167
Santa Clara 139
Beijing 136
Chicago 126
Toronto 124
Dallas 121
Jakarta 106
Seoul 105
The Dalles 103
Woodbridge 99
Seattle 95
Rome 79
São Paulo 79
Council Bluffs 78
Dearborn 76
Buffalo 67
Jacksonville 67
Lauterbourg 67
Shanghai 64
Princeton 61
Cambridge 57
Helsinki 51
Tokyo 49
Moscow 44
Bergamo 41
Munich 41
Denver 39
Haiphong 38
Turin 38
Johannesburg 35
Montreal 34
Nanjing 33
Orem 30
Monza 28
Warsaw 28
Boardman 27
Nuremberg 27
Lawrence 26
Baghdad 25
London 25
Chennai 24
Da Nang 24
Hải Dương 24
Lappeenranta 24
Atlanta 23
Lahore 23
Brussels 21
Guangzhou 21
Stockholm 21
Zurich 21
Altamura 20
Brooklyn 20
Figino 20
Biên Hòa 19
Mumbai 19
Phoenix 19
Rio de Janeiro 19
Lissone 18
Naples 18
San Diego 18
Ankara 17
Bologna 17
Turku 17
Bắc Ninh 16
Dhaka 16
Jeddah 15
Memphis 15
Ottawa 15
Poplar 15
Vienna 15
Belo Horizonte 14
Borgomanero 14
Brasília 14
Can Tho 13
Ha Long 13
Jinan 13
Mexico City 13
Tianjin 13
Amsterdam 12
Carate Brianza 12
Carrboro 12
Florence 12
Hyderabad 12
Ninh Bình 12
Totale 9.875
Nome #
Acute myeloid leukaemia niche regulates response to L-asparaginase 446
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 428
Zoledronic Acid in a Mouse Model of Human Fibrous Dysplasia: Ineffectiveness on Tissue Pathology, Formation of “Giant Osteoclasts” and Pathogenetic Implications 402
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 392
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 368
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 364
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 362
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 343
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 341
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 338
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 335
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 333
Characterization of Plated Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects 327
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 305
Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis 301
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I 279
Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease 271
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 270
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 270
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis 270
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability 265
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML 265
Catch me if you can: how AML and its niche escape immunotherapy 260
Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I 257
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 253
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia 253
Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential 252
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta 252
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 251
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 250
Isolation of single circulating trophoblasts from maternal circulation for noninvasive fetal copy number variant profiling 245
Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia 244
CARs are sharpening their weapons 244
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia 239
Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors 233
Elongation factor 1 (EF1α) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis 231
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency 223
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 221
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia 221
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 221
Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation 221
Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better? 219
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche 218
Detailed investigation of obstetric factors influencing isolation efficiency of fetal mesenchymal stem cells (FMSCS) from amniotic fluid and cord blood samples 213
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling 212
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare 209
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies 202
Establishment of bone marrow and hematopoietic niches in vivo by reversion of chondrocyte differentiation of human bone marrow stromal cells 201
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies 200
Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells 199
An in vivo humanized model to study homing and sequestration of Plasmodium falciparum transmission stages in the bone marrow. 190
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche 176
CD14 positive cells accelerate hematopoietic stem cell engraftment 164
Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery 163
MPSI Manifestations and Treatment Outcome: Skeletal Focus 162
Defective IL-10-mediated modulation of monocytes from autoimmune patients 145
mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy 131
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I 119
GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells 117
Effect of Aplidin in acute lymphoblastic leukaemia cells 115
From stem cells to bone-forming cells 111
Morphological and immunophenotypical changes of human bone marrow adipocytes in marrow metastasis and myelofibrosis. 109
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia 109
Solitary juvenile xanthogranuloma of the hypopharynx. Clinico-pathologic study in a child with β-Thalassemia Major and Cutaneous Mastocytosis 102
A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors 101
Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches 92
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2 91
Hematopoietic reconstitution by multipotent adult progenitor cells: Precursors to long-term hematopoietic stem cells 90
Gene Therapy for Mucopolysaccharidoses: In Vivo and Ex Vivo Approaches 89
Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors 88
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future 87
No identical "mesenchymal stem cells" at different times and sites: Human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels 77
Lentiviral vectors show dramatically increased efficiency of transduction of human leukemic cell lines 77
Pluripotency in adult stem cells: State of the art 74
A comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experience 66
Effects of anti-RANKL, Zoledronate or combination therapy in a mouse model of fibrous dysplasia: a preclinical study 63
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches 47
Totale 16.674
Categoria #
all - tutte 53.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022624 63 61 63 54 44 50 25 19 34 43 42 126
2022/2023993 112 248 70 108 29 144 24 69 71 12 80 26
2023/20241.282 41 36 57 78 105 287 163 137 143 49 40 146
2024/20253.076 155 270 222 135 239 202 215 100 286 446 304 502
2025/20268.499 1.173 685 560 975 918 373 1.191 360 617 726 397 524
2026/202770 70 0 0 0 0 0 0 0 0 0 0 0
Totale 16.674